As an extra meeting place between exhibitors, visitors & press located on the show floor, speakers will be presenting the industry about their products, services, new launches, innovations and news. These sessions are free to attend to all visitors to CPHI Korea and co-located events.

Free Seminar

8.30(Wed) Seminar Room
2023 스케줄
Session Number Time Title Organisation / Company Speaker Language
D-1 10:30 - 12:20 The Strategy & Application of Innovative Manufacturing in the United States KOREA INSTITUTE OF TOXICOLOGY
10:30 - 11:10 The meaning of 'National Biotechnology and Biomanufacturing Initiative' and our response Korea Pharmaceutical and Bio-Pharma Manufacturers Association Chi-Min Kim, Policy Department, Researcher Team, Director K
11:10 - 11:40 Highlights of the U.S. Executive Order and Our Assignment Korea Research Institute of Bioscience and Biotechnology Hyeon su KIM, Team Manager K
11:40 - 12:20 Unlocking the Potential: Case Studies of Bio Supply Chain Utilization Plan Korea-US Supply Chain Management Institute (KUSCMI) Park Young Ho, Representative K
D-3 12:20 - 12:50 Elsevier’s Life Science Solutions for Pharmaceutical Research Elsevier Sejin Kim, Customer Consultant K
D-4 13:00 - 13:20 The potential of Gelucire® 44/14 as a solubilizer and its pharmaceutical applications in SEDDS(Self-emulsifying drug delivery system) formulation College of Pharmacy, Chung-Ang University Prof Sangkil LEE E
13:20 - 13:45 Benefits of lipid excipients for poorly soluble drugs in Liquid SEDDS formulations
13:45 - 14:10 Benefits of lipid excipients for poorly soluble drugs in solid SEDDS formulations Gattefosse SAS MSc. Philippe CAISSE, Scientific Director Pharmaceuticals E
D-6 14:20 - 14:50 The Health Benefits and Application Advantages of FloraFocus® Probiotics from BioGrowing BIOGRWOING CO., LTD Dr. Haidi XU, Vice President E
D-7 15:00 - 15:10 Entry Strategy into Emerging Countries - Ghana, Timor-Leste, DR Congo UNIDO ITPO Korea, Health Service, Ghana Sylvester Chinbuah, Senior Biomedical Scientist E
15:10 - 15:20 UNIDO ITPO Korea, Health Service, Ministry of Health, Timor-Leste Filomeno Pinto Moniz, General Practitioner, Medical Coordinator E
15:20 - 15:30 UNIDO ITPO Korea, Central Military Hospital, DR Congo Mulolwa Muzaliwa Pascal, Doctor supervisor E
D-8 15:40 - 16:10 Recombinant human collagen Ⅲ - A rising star in the field of anti-aging，tissue repair and regeneration MISOU Clinic, Shenyang, China Dr. Yang Kiyoung K
D-9 16:20 – 16:50 HAPLEX™ Hyaluronic Acid, More Than Inner Beauty, Tapping into holistic wellbeing Bloomage Biotechnology Corporation Limited Jean Zhao, Marketing Director E
8.31(Thu) Seminar Room
2023 스케줄
Session Number Time Title Organisation / Company Speaker Language
E-1 10:15 - 11:25 Permeation enhancers for improving bioavailability of poorly permeable drugs Gattefosse Asia Pacific Pte. Ltd. Dr. Hongyi Ouyang, Technical Marketing Specialist E
Gattefosse SAS MSc. Philippe CAISSE, Scientific Director Pharmaceuticals E
E-3 11:35 – 12:05 Graminex® Flower Pollen Extracts for Men’s and Women's Health Graminex Korea Dr. Sun-Ho Frank Kim, Managing Director K
Graminex LLC Dr. Alex Grantz, Chief Scientific Officer E
E-4 13:00 - 14:45 2023 Briefing and Conference on Advanced Technologies in Functional Food materials Korea Agriculture Technology Promotion Agency K
13:00 - 13:15 Opening Korea Agriculture Technology Promotion Agency Lee Hyeon Seok, Team Manager K
13:15 - 13:30 Functional food composition for improving cognitive ability and treating degenerative brain disease comprising an extract of Allium hookeri National Institute of Agricultural Sciences, RDA Sung Hen Lee, Senior Scientist, Lab. leader of Functional Foods Evaluation, Dept. of Functional Foods K
13:30 - 13:45 Novel ganoderma lucidum strain with increased functional bioactive components National institute of Horticultural and Herbal Science YounLee Oh, Senior Scientist K
13:45 - 14:00 1. Antidiabetic red bean extract composition for lowering blood glucose level and increasing diet effect
2. Composition for preventing, improving or treating non-alcoholic fatty liver disease comprising red bean extract 		National Institute of Crop Science LEE BYONGWON, Researcher K
14:00 - 14:15 1. Composition for enhancing immune function comprising chestnut honey as an active ingredient
2. Pharmaceutical composition for preventing or treating of diseases caused by influenza A virus comprising chestnut honey as an active ingredient 		National Institute of Agricultural Sciences Choi Hong Min, Agricultural Researcher K
14:15 - 14:30 A cultivation method of enhancing immune bioactivity of oat grains National Institute of Crop Sciences Kim Dea-wook, Researcher K
14:30 - 14:45 1. Effect of oat husk extract on menopausal symptoms
2. Effect of corn leaf extract on periodontal disease improvement 		National Institute of Crop Science Lee Mi Ja, Agricultural Researcher K
E-7 15:00 - 15:30 BASF vitamins and carotenoids with Microencapsulation technology BASF Yuki Kobayashi, BASF Japan, Nutrition & Health Manager E
E-8 15:40 - 16:10 The Art of Improving Medication Acceptance in Pediatrics: Making Medicines Taste Better Adare Pharma Solutions PhD. Srinivasan Shanmugam, Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies E
E-9 16:20 – 16:50 USP Dietary Supplement Standards & Verification Programs – Making Quality Visible United States Pharmacopeia Nam Cheol Kim, Principal Scientist K
Seong Jae (SJ) Yoo, Senior Manager K
9.01(Fri) Seminar Room
2023 스케줄
Session Number Time Title Organisation / Company Speaker Language
F-1 10:20 – 10:50 Clostridium butyricum K-Butyric acid bacteria NPK Co., Ltd JO GYUNG HYUN, Principal Research Engineer K
F-2 11:00 – 11:30 Liposomal Botanicals and Nutraceuticals Botanic Healthcare Pvt Ltd., INDIA Dr. H N Shivaprasad, Director-Global Business E
F-3 11:40 – 12:10 Vitamin K2-7 - A Multi-tasking Vitamin EverSpring Co., ltd. Mikkel Jungersen, M.Sc., Advisor to Everspring E
F-5 13:00 – 13:30 Various effects of mass-produced rare ginsenoside Compound K, and its usage as a functional ingredient for natural medicine and health foods AceEMzyme Wan-Taek Im, CEO K
F-6 13:40 - 15:30 Case Announcement of Implementation of the Nagoya Protocol and Access and Benefit-Sharing on genetic resources National Institute of Biological Resources K
Implementation of the Nagoya Protocol(and ABS) and ESG Compliance Lee & KO ESG Team Seol Tong Keun, Team leader K
Nagoya Protocol compliance case: Hanmi Pharmaceutical Group Hanmi Pharmaceutical Jisun Nam, Head of Legal Department K
Implementation of the Nagoya Protocol(and ABS) and notification Cosmax Yong Seok Jwon, Legal Department Chief Legal Officer K

*The above schedule is subject to change without prior notice due to the circumstances of the organizer and speakers.